Author:
Thrash-Williams Bessy,Ahuja Manuj,Karuppagounder Senthilkumar S.,Uthayathas Subramaniam,Suppiramaniam Vishnu,Dhanasekaran Muralikrishnan
Publisher
Springer Science and Business Media LLC
Subject
Cellular and Molecular Neuroscience,General Medicine,Biochemistry
Reference68 articles.
1. Goetz CG (1998) New lessons from old drugs: amantadine and Parkinson’s disease. Neurology 50:1211–1212
2. Verhagen ML, Del Dotto P, van den Munckhof P (1998) Amantadine as treatment for dyskinesias and motor fluctuations in Parkinson’s disease. Neurology 50:1323–1326
3. Leone H, Polsonetti BW (2005) Amantadine for traumatic brain injury: does it improve cognition and reduce agitation? J Clin Pharm Ther 30:101–104
4. Rogoz Z, Skuza G, Daniel WA, Wojcikowski J, Dudek D, Wrobel A (2007) Amantadine as an additive treatment in patients suffering from drug-resistant unipolar depression. Pharmacol Rep 59:778–784
5. Uitti RJ, Rajput AH, Ahlskog JE, Offord KP, Schroeder DR, Ho MM, Prasad M, Rajput A, Basran P (1996) Amantadine treatment is an independent predictor of improved survival in Parkinson’s disease. Neurology 46:1551–1556
Cited by
16 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献